Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease: Results from a Phase 3 double-blind, placebo-controlled trial Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pahwa, R
  • Hauser, R
  • Worden, M
  • Bhargava, P
  • Vakili, G
  • Agro, Albert
  • Blum, D
  • Olanow, W
  • Navia, B

publication date

  • October 1, 2018